IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

An abnormal Pap smear result doesn’t necessarily mean you have cervical cancer. Your doctor may recommend further testing as a next step.

Obesity is now linked to at least 13 types of cancer, making it one of the most preventable cancer risk factors in the United ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

Heaven’s Beverley Mitchell reflected on a life-changing experience when doctors found the “biggest precancerous polyp” on her ...

About 1 in 5 Americans will develop skin cancer in their lifetime. But unlike some other types, skin cancer can often be prevented!

Suspicious cells build up in mice that haven’t given birth, a new study finds. They could help explain a longstanding mystery ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...